BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9223548)

  • 1. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.
    Escrig V; Ubeda A; Ferrandiz ML; Darias J; Sanchez JM; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):123-31. PubMed ID: 9223548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.
    Cholbi R; Ferrándiz ML; Terencio MC; De Rosa S; Alcaraz MJ; Payá M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):677-83. PubMed ID: 8938669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.
    Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ
    Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses.
    Gil B; Sanz MJ; Terencio MC; De Giulio A; De Rosa S; Alcaraz MJ; Payá M
    Eur J Pharmacol; 1995 Oct; 285(3):281-8. PubMed ID: 8575515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
    Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
    J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice.
    Ferrándiz ML; Gil B; Sanz MJ; Ubeda A; Erazo S; González E; Negrete R; Pacheco S; Payá M; Alcaraz MJ
    J Pharm Pharmacol; 1996 Sep; 48(9):975-80. PubMed ID: 8910867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity.
    Gil B; Sanz MJ; Terencio MC; Gunasegaran R; Payá M; Alcaraz MJ
    Biochem Pharmacol; 1997 Mar; 53(5):733-40. PubMed ID: 9113093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
    Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
    Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
    García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ
    Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
    Tramposch KM; Chilton FH; Stanley PL; Franson RC; Havens MB; Nettleton DO; Davern LB; Darling IM; Bonney RJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):852-9. PubMed ID: 7965805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.
    Burke JR; Davern LB; Stanley PL; Gregor KR; Banville J; Remillard R; Russell JW; Brassil PJ; Witmer MR; Johnson G; Tredup JA; Tramposch KM
    J Pharmacol Exp Ther; 2001 Jul; 298(1):376-85. PubMed ID: 11408565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
    Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
    Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
    Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
    Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
    Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
    Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
    Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
    Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naturally occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism.
    Hernández V; Recio MC; Máñez S; Giner RM; Ríos JL
    Life Sci; 2007 Jul; 81(6):480-8. PubMed ID: 17658557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.